Publicacions en què col·labora amb P. Coto-Segura (34)

2024

  1. Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

2023

  1. The IFIH1/MDA5 rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

2021

  1. Genetic variants of the NF-κB pathway: Unraveling the genetic architecture of psoriatic disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2019

  1. NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis

    Molecular Diagnosis and Therapy, Vol. 23, Núm. 5, pp. 627-633

  2. Gene Variant in the NF- κ B Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease

    BioMed Research International, Vol. 2019

  3. Gut microbiota dysbiosis in a cohort of patients with psoriasis

    British Journal of Dermatology, Vol. 181, Núm. 6, pp. 1287-1295

2018

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function

    Human Immunology, Vol. 79, Núm. 6, pp. 494-498

  2. Genetic Variation in the H19-IGF2 Cluster Might Confer Risk of Developing Impaired Renal Function

    DNA and Cell Biology, Vol. 37, Núm. 7, pp. 617-625

  3. IL17RA gene variants and anti-TNF response among psoriasis patients

    Pharmacogenomics Journal, Vol. 18, Núm. 1, pp. 76-80

2017

  1. NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant

    Human Immunology, Vol. 78, Núm. 5-6, pp. 435-440

2016

  1. A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis

    PLoS ONE, Vol. 11, Núm. 7

  2. Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis

    British Journal of Dermatology, Vol. 175, Núm. 1, pp. 134-141

  3. KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort

    Molecular and Cellular Endocrinology, Vol. 427, pp. 86-91

2015

  1. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort

    Journal of Dermatological Science, Vol. 80, Núm. 2, pp. 111-115

  2. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

    Human Immunology, Vol. 76, Núm. 2-3, pp. 75-78

  3. CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients

    International Immunopharmacology, Vol. 29, Núm. 2, pp. 947-949

  4. Cardiovascular risk factors influence response to biological therapies in psoriasis

    Journal of the American Academy of Dermatology, Vol. 73, Núm. 2, pp. 327-329

  5. Influence of Fcγ receptor polymorphisms on response to anti-tumor necrosis factor treatment in psoriasis

    JAMA Dermatology

  6. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients

    Pharmacogenetics and Genomics, Vol. 25, Núm. 6, pp. 313-316

  7. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients

    Archives of Dermatological Research, Vol. 307, Núm. 5, pp. 405-412